Petrus Trust Company, Lta Lantheus Holdings, Inc. Transaction History

Petrus Trust Company, Lta

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$11.98 - $16.34 $193,704 - $264,201	-16,169 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$10.34 - $15.51 $38,226 - $57,340	-3,697 Reduced 18.61%	16,169 $231,000
Q1 2020 May 15, 2020	BUY	$9.11 - $20.05 $180,979 - $398,313	19,866 New	19,866 $253,000
Q3 2019 Nov 14, 2019	SELL	$21.01 - $28.94 $290,778 - $400,529	-13,840 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$23.33 - $28.3 $96,399 - $116,935	-4,132 Reduced 22.99%	13,840 $392,000
Q1 2019 May 15, 2019	BUY	$14.93 - $25.1 $103,330 - $173,717	6,921 Added 62.63%	17,972 $440,000
Q4 2018 Feb 14, 2019	BUY	$12.68 - $19.01 $140,126 - $210,079	11,051 New	11,051 $173,000
Q3 2018 Nov 14, 2018	SELL	$13.1 - $16.35 $288,972 - $360,664	-22,059 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.65 - $18.7 $123,177 - $168,748	9,024 Added 69.23%	22,059 $321,000
Q1 2018 May 15, 2018	SELL	$14.85 - $24.3 $165,221 - $270,361	-11,126 Reduced 46.05%	13,035 $207,000
Q4 2017 Feb 14, 2018	SELL	$17.4 - $23.4 $19,644 - $26,418	-1,129 Reduced 4.46%	24,161 $494,000
Q3 2017 Nov 14, 2017	BUY	$15.5 - $19.15 $391,995 - $484,303	25,290	25,290 $450,000

540

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

Stay updated on Petrus Trust Company, Lta with notifications on news.